Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProCore Bio
Suzhou, Jiangsu, Chinaprocorebio.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
ProCore Bio-Med is a biotechnology company specializing in the development and manufacture of high-quality recombinant proteins, cytokines, and enzymes for the cell and gene therapy (CGT) industry. Based in Suzhou, China, the company provides GMP-grade raw materials such as IL-2, IL-7, and IL-15, which are essential for the expansion and differentiation of immune cells. ProCore Bio-Med leverages its proprietary protein expression and purification platforms to ensure high bioactivity, purity, and consistency across its product lines. The company serves global biopharmaceutical firms and research institutions, supporting the advancement of regenerative medicine and immunotherapy.
- Therapeutic areas
- OncologyImmunologyOther
- Modalities
- Recombinant proteinCytokineEnzyme
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on ProCore Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProCore Bio.